Inhibition of CCAAT/enhancer binding protein family DNA binding in mouse epidermis prevents and regresses papillomas

Cancer Research

Volumn 67, Issue 4, 2007, Pages 1867-1876

  Won, Jun Oh ^a   Rishi, Vikas ^a   Orosz, Andras ^a   Gerdes, Michael J ^b   Vinson, Charles ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GE GLOBAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; DOXYCYCLINE; KERATIN; PROTEIN P53; TETRACYCLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DNA BINDING; EPIDERMIS; HAIR LOSS; HETEROZYGOSITY; HYPERPLASIA; KERATINOCYTE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; UPREGULATION;

ANIMALS; APOPTOSIS; CCAAT-ENHANCER-BINDING PROTEINS; CELL GROWTH PROCESSES; DNA; KERATINOCYTES; MICE; MICE, TRANSGENIC; PAPILLOMA; SKIN; SKIN NEOPLASMS;

EID: 33847719801     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-2746     Document Type: Article

References (45)

1. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998;273:28545-8.
2. Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev 1994;8:1654-63.
3. Buck M, Poli V, Hunter T, Chojkier M. C/EBPβ phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Mol Cell 2001;8:807-16.
4. Akira S, Isshiki H, Sugita T, et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J 1990;9:1897-906.
5. Osada S, Yamamoto H, Nishihara T, Imagawa M. DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. J Biol Chem 1996;271:3891-6.
6. Ubeda M, Wang XZ, Zinszner H, Wu I, Habener JF, Ron D. Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol Cell Biol 1996;16:1479-89.
7. Ryden TA, Beemon K. Avian retroviral long terminal repeats bind CCAAT/enhancer-binding protein. Mol Cell Biol 1989;9:1155-64.
8. Moll JR, Acharya A, Gal J, Mir AA, Vinson C. Magnesium is required for specific DNA binding of the CREB B-ZIP domain. Nucleic Acids Res 2002;30:1240-6.
9. Newman JR, Keating AE. Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 2003;300:2097-101.
10. Linhart HG, Ishimura-Oka K, DeMayo F, et al. C/EBPα is required for differentiation of white, but not brown, adipose tissue. Proc Natl Acad Sci U S A 2001;98:12532-7.
11. Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPβ and/or C/EBPδ gene. EMBO J 1997;16:7432-43.
12. Cao Z, Umek RM, McKnight SL. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-1 cells. Genes Dev 1991;5:1538-52.
13. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995;64:345-73.
14. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev 1995;9:168-81.
15. Friedman AD, Landschulz WH, McKnight SL. CCAAT/enhancer binding protein activates the promoter of the serum albumin gene in cultured hepatoma cells. Genes Dev 1989;3:1314-22.
16. Bull JJ, Muller-Rover S, Chronnell CM, Paus R, Philpott MP, McKay LA. Contrasting expression patterns of CCAAT/enhancer-binding protein transcription factors in the hair follicle and at different stages of the hair growth cycle. J Invest Dermatol 2002;118:17-24.
17. Zhu S, Oh HS, Shim M, Sterneck E, Johnson PF, Smart RC. C/EBPβ modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol Cell Biol 1999;19:7181-90.
18. Oh HS, Smart RC. Expression of CCAAT/enhancer binding proteins (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol 1998;110:939-45.
19. Swart GW, van Groningen JJ, van Ruissen F, Bergers M, Schalkwijk J. Transcription factor C/EBPα: novel sites of expression and cloning of the human gene. Biol Chem 1997;378:373-9.
20. Maytin EV, Lin JC, Krishnamurthy R, et al. Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev Biol 1999;216:164-81.
21. Maytin EV, Habener JF. Transcription factors C/EBPα, C/EBPβ, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 1998;110:238-46.
22. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003;3:89-101.
23. Bundy LM, Sealy L. CCAAT/enhancer binding protein β (C/EBPβ)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 2003;22:869-83.
24. Rask K, Thorn M, Ponten F, et al. Increased expression of the transcription factors CCAAT-enhancer binding protein-β (C/EBβ) and C/EBζ (CHOP) correlate with invasiveness of human colorectal cancer. Int J Cancer 2000;86:337-43.
25. Sundfeldt K, Ivarsson K, Carlsson M, et al. The expression of CCAAT/enhancer binding protein (C/EBP) in the human ovary in vivo: specific increase in C/EBPβ during epithelial tumour progression. Br J Cancer 1999;79:1240-8.
26. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC. CCAAT/enhancer binding protein-β is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proc Natl Acad Sci U S A 2002;99:207-12.
27. Screpanti I, Romani L, Musiani P, et al. Lymphoproliferative disorder and unbalanced T-helper response in C/EBPβ-deficient mice. EMBO J 1995;14:1932-41.
28. Sterneck E, Zhu S, Ramirez A, Jorcano JL, Smart RC. Conditional ablation of C/EBPβ demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis. Oncogene 2006;25:1272-6.
29. Krylov D, Olive M, Vinson C. Extending dimerization interfaces: the bZIP basic region can form a coiled coil. EMBO J 1995;14:5329-37.
30. Vinson C, Myaldshev M, Acharya A, Mir AA, Moll JR, Bonovich M. Classification of human B-ZIP proteins based on dimerization properties. Mol Cell Biol 2002;22:6321-35.
31. Diamond I, Owolabi T, Marco M, Lam C, Glick A. Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. J Invest Dermatol 2000;115:788-94.
32. Gerdes MJ, Myakishev M, Frost NA, et al. Activator protein-1 activity regulates epithelial tumor cell identity. Cancer Res 2006;66:7578-88.
33. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992;356:215-21.
34. Inoue Y, Hayhurst GP, Inoue J, Mori M, Gonzalez FJ. Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4α (HNF4α). HNF4α regulates ornithine transcarbamylase in vivo. J Biol Chem 2002;277:25257-65.
35. Yuspa SH, Dlugosz AA, Cheng CK, et al. Role of oncogenes and tumor suppressor genes in multistage carcinogenesis. J Invest Dermatol 1994;103:90-5S.
36. Yuspa SH, Dlugosz AA, Denning MF, Glick AB. Multistage carcinogenesis in the skin. J Investig Dermatol Symp Proc 1996;1:147-50.
37. Bonovich M, Olive M, Reed E, O'Connell B, Vinson C. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines. Cancer Gene Ther 2002;9:62-70.
38. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 1992;89:5547-51.
39. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995;268:1766-9.
40. Turnbull L, Zhou HZ, Swigart PM, et al. Sustained preconditioning induced by cardiac transgenesis with the tetracycline transactivator. Am J Physiol Heart Circ Physiol 2006;290:H1103-9.
41. 1 checkpoint in keratinocytes. Mol Cell Biol 2004;24:10650-60.
42. Harvey M, McArthur MJ, Montgomery CA, Jr., Butel JS, Bradley A, Donehower LA. Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nat Genet 1993;5:225-9.
43. Woodworth CD, Michael E, Smith L, et al. Strain-dependent differences in malignant conversion of mouse skin tumors is an inherent property of the epidermal keratinocyte. Carcinogenesis 2004;25:1771-8.
44. Schneider-Merck T, Pohnke Y, Kempf R, Christian M, Brosens JJ, Gellersen B. Physical interaction and mutual transrepression between CCAAT/enhancer- binding protein β and the p53 tumor suppressor. J Biol Chem 2006;281:269-78.
45. Rishi V, Potter T, Laudeman J, et al. A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. Anal Biochem 2005;340:259-71.